Does Professional CGM Decrease the Economic Burden of T2D?
Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.
Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.
Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.
Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.
With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.
Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.
New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.
Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.
Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.